Capital International Investors’s Integra LifeSciences IART Stock Holding History

Capital International Investors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-193,200	Closed	-$12.5M	–	451
2020 Q4	$12.5M	Hold	193,200	–	–	﹤0.01%	403
2020 Q3	$9.12M	Hold	193,200	–	–	﹤0.01%	402
2020 Q2	$9.08M	Sell	193,200 -6	-0%	-$295	﹤0.01%	379
2020 Q1	$8.63M	Sell	193,206 -1,048,462	-84%	-$55M	﹤0.01%	355
2019 Q4	$72.4M	Sell	1,241,668 -42,346	-3%	-$2.52M	0.02%	248
2019 Q3	$77.1M	Sell	1,284,014 -458,245	-26%	-$27.3M	0.03%	244
2019 Q2	$97.3M	Sell	1,742,259 -527,349	-23%	-$27.2M	0.04%	239
2019 Q1	$126M	Buy	2,269,608 +143,823	+7%	+$7.32M	0.05%	213
2018 Q4	$95.9M	Buy	+2,125,785	New	+$117M	0.05%	213

Other funds holding IART

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors's IART Position: Q1 2021 in Review

Capital International Investors sold out of Integra LifeSciences (IART) in Q1 2021, closing a stake of 193,200 shares — an estimated $12.5M sold.

Capital International Investors first reported a position in IART in Q4 2018 and held it in 9 quarters. The position peaked at $126M in Q1 2019. 257 funds tracked by Wall St. Rank hold IART as of Q1 2021.

Capital International Investors reported no remaining Integra LifeSciences position as of Q1 2021 after selling out during the quarter.
Capital International Investors sold 193,200 Integra LifeSciences shares in Q1 2021, an estimated $12.5M.
Capital International Investors first reported a position in Integra LifeSciences in Q4 2018 and held it in 9 quarters.
Capital International Investors's Integra LifeSciences position peaked at $126M in Q1 2019.
257 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2021.

Based on Capital International Investors's 13F filing for Q1 2021, filed 14 May 2021.